Furthermore, the prognostic significance of FOXO6 in different risk of subgroups based on tumor size, depth of invasion and lymph node metastasis was assessed, which appeared that FOXO6 could be a negative prognostic biomarker for different risks of gastric cancer patients. This evidence concerns the gene FOXO6 and neoplasm.